Vidofludimus

Vidofludimus (SC12267, 4SC-101) is an orally active and potent dihydroorotate dehydrogenase (DHODH) inhibitor with IC50 of 134 nM for human DHODH. Vidofludimus calcium (IMU-838) is investigated as a potential treatment option for COVID-19. Phase 2.
Supplier Selleck Chemicals
Product # S7262
Sku # S7262-5mg
Pricing 5mg, $147.00
Feedback